
AstraZeneca Appoints Ram Mudaliar as the India Lead of its CDI Division

AstraZeneca India Private Limited, has appointed Ram Mudaliar as the India lead of its Clinical Data & Insights (CDI) division.
CDI division in Bengaluru, is a critical advancement to support a growing global portfolio and build on internal data expertise. Ram’s appointment follows the launch of the CDI India division in October last year.
As CDI India Lead, Ram will be responsible for establishing and expanding the CDI footprint in India, liaising with CDI global and local leaders to develop and implement strategic decisions for the India site.
He is also responsible for ensuring the local planning and coordination relating to facilities and enabling support for the India team, connecting with Facilities Management, Human Resources, IT, Compliance, R&D Site Leadership and other functions as required.
Siva Padmanabhan, Managing Director, AstraZeneca India Private Limited, says, “Clinical Data & Insights play a very important role in gaining visibility into patient journey and providing actionable insights. The launch of Clinical Data & Insights team in Bengaluru, India, is a critical advancement to support a growing global portfolio, and build on internal data expertise. Ram’s depth of experience in data management, leadership, strategic insights and broad-based expertise will be an accelerator to the growth of the AstraZeneca’s Clinical Data & Insights Division in India.”
AstraZeneca CDI's current footprint includes over 400 employees, and approximately 700 data management professionals in vendor partnerships across six countries and embedding data science and Artificial Intelligence (AI)across R&D centres to enable their data teams to push the boundaries of science to deliver life-changing medicines.
Ram worked with AstraZeneca Canada, managing delivery of the Lung portfolio and leading Oncology data management teams in the North American region and in Europe.
Prior to his appointment as the CDI India Lead, Ram worked with AstraZeneca Canada, managing delivery of the Lung portfolio and leading Oncology data management teams in the North American region and in Europe. He has also worked as Interim Global Head of Oncology in Data Management for a brief period.